Cholesterol lowering in patients with CHD and metabolic syndrome.
Caputo
Fabio
F
Bernardi
Mauro
M
D000069059:Atorvastatin; D003327:Coronary Disease / Q000150:complications / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D000431:Ethanol / Q000008:administration & dosage / Q000627:therapeutic use*; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D024821:Metabolic Syndrome / Q000150:complications*; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use*
D006538:Heptanoic Acids; D011758:Pyrroles; D000431:Ethanol; D000069059:Atorvastatin